Simplex Trading
TEVA icon

Simplex Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Simplex Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.97M Buy
+330,900
New +$10.6M 0.01% 700
2025
Q4 		– Sell
-746,200
Closed -$15.1M – 10047
2025
Q3 		$15.1M Buy
746,200
+85,100
+13% +$1.49M 0.01% 749
2025
Q2 		$11.1M Sell
661,100
-68,200
-9% -$1.1M 0.01% 821
2025
Q1 		$11.2M Sell
729,300
-153,200
-17% -$2.74M 0.01% 824
2024
Q4 		$19.4M Buy
882,500
+184,400
+26% +$3.35M 0.01% 652
2024
Q3 		$12.6M Buy
698,100
+216,200
+45% +$3.78M 0.01% 898
2024
Q2 		$7.83M Sell
481,900
-774,700
-62% -$11.9M ﹤0.01% 1168
2024
Q1 		$17.7M Buy
1,256,600
+148,300
+13% +$1.87M 0.01% 776
2023
Q4 		$11.6M Sell
1,108,300
-26,900
-2% -$251K 0.01% 994
2023
Q3 		$11.6M Sell
1,135,200
-341,600
-23% -$3.18M 0.01% 852
2023
Q2 		$11.1M Sell
1,476,800
-235,100
-14% -$1.91M 0.01% 834
2023
Q1 		$15.2M Buy
1,711,900
+285,600
+20% +$2.82M 0.01% 698
2022
Q4 		$13M Buy
1,426,300
+276,300
+24% +$2.41M 0.01% 739
2022
Q3 		$9.28M Sell
1,150,000
-153,800
-12% -$1.36M 0.01% 838
2022
Q2 		$9.8M Sell
1,303,800
-186,900
-13% -$1.63M 0.01% 798
2022
Q1 		$14M Buy
1,490,700
+245,700
+20% +$2.05M 0.01% 676
2021
Q4 		$9.97M Buy
1,245,000
+693,300
+126% +$6.26M 0.01% 786
2021
Q3 		$5.47M Sell
551,700
-4,100
-0.7% -$38.4K 0.01% 1121
2021
Q2 		$5.5M Buy
555,800
+550,620
+10,630% +$5.83M 0.01% 1097
2021
Q1 		$5.98M Sell
5,180
-944
-15% -$10.8K 0.01% 697
2020
Q4 		$5.91M Sell
6,124
-2,424
-28% -$23.2K 0.01% 870
2020
Q3 		$7.7M Sell
8,548
-1,902
-18% -$20.1K 0.01% 634
2020
Q2 		$12.9M Sell
10,450
-1,170
-10% -$13.2K 0.02% 421
2020
Q1 		$10.4M Buy
11,620
+2,914
+33% +$29.9K 0.02% 399
2019
Q4 		$8.53M Buy
8,706
+400
+5% +$3.57K 0.02% 525
2019
Q3 		$5.71M Buy
8,306
+2,873
+53% +$22K 0.02% 649
2019
Q2 		$5.01M Buy
5,433
+2,903
+115% +$35K 0.01% 678
2019
Q1 		$3.97M Sell
2,530
-5,804
-70% -$102K 0.01% 839
2018
Q4 		$12.9M Buy
8,334
+3,647
+78% +$74.8K 0.04% 286
2018
Q3 		$10.1M Buy
4,687
+2,373
+103% +$55.1K 0.03% 365
2018
Q2 		$5.63M Sell
2,314
-480
-17% -$9.79K 0.02% 519
2018
Q1 		$807K Sell
2,794
-33
-1% -$644 0.04% 478
2017
Q4 		$576K Sell
2,827
-1,078
-28% -$16.2K 0.02% 641
2017
Q3 		$3.32M Buy
3,905
+449
+13% +$10.1K 0.14% 117
2017
Q2 		$922K Sell
3,456
-2,363
-41% -$73.1K 0.04% 395
2017
Q1 		$1.55M Buy
5,819
+3,583
+160% +$122K 0.07% 261
2016
Q4 		$1.06M Sell
2,236
-500
-18% -$20K 0.06% 271
2016
Q3 		$1.46M Buy
2,736
+608
+29% +$31.7K 0.1% 188
2016
Q2 		$832K Buy
2,128
+1,091
+105% +$58.1K 0.06% 336
2016
Q1 		$246K Buy
1,037
+151
+17% +$8.86K 0.02% 757
2015
Q4 		$162K Sell
886
-483
-35% -$29.8K 0.01% 1025
2015
Q3 		$1.07M Buy
1,369
+360
+36% +$23.3K 0.08% 222
2015
Q2 		$519K Buy
1,009
+453
+81% +$27.9K 0.04% 386
2015
Q1 		$49K Sell
556
-524
-49% -$30.5K 0.01% 1585
2014
Q4 		$104K Buy
+1,080
New +$60.2K 0.01% 916

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's TEVA Position: Q1 2026 in Review

Simplex Trading opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 11,315 shares worth $341K. The stake represents ﹤0.01% of the portfolio and ranks #3681 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TEVA as recently as Q3 2025.

Simplex Trading first reported a position in TEVA in Q4 2014 and has held it in 37 quarters since. The position peaked at $11.6M in Q4 2022. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Simplex Trading held 11,315 shares of Teva Pharmaceuticals worth $341K as of Q1 2026.
  • Teva Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3681 holding.
  • Simplex Trading first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 37 quarters since.
  • Simplex Trading's Teva Pharmaceuticals position peaked at $11.6M in Q4 2022.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.